RA Capital Management
VC · Boston (United States)
VC
Pre-Seed
Seed
AI
Hardware
Sign up free to access full profile and submit your pitch.
About
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies. Their portfolio encompasses a wide range of sectors, including pharmaceuticals, medical devices, diagnostics, services, and research tools. The firm is committed to advancing healthcare by supporting companies that are developing innovative solutions to improve patient outcomes. RA Capital Management operates with a focus on scientific rigor and a deep understanding of the healthcare landscape, enabling them to make informed investment decisions that drive meaningful progress in the industry.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Min. Ticket Size
$0
Max. Ticket Size
$75,000,000
Investment Stage
Pre-Seed
Seed
Series A
Series B
Series C
Focus Areas
Countries
Regions
North America
Co-Investors of RA Capital Management
Other investors that have backed the same portfolio companies as RA Capital Management. Expand any entry to see the shared portfolio companies.
- 52 shared
Shared portfolio companies
- ACADIA Pharmaceuticals Inc.
- Achilles Therapeutics plc
- Adaptimmune Therapeutics plc
- Adcendo ApS
- Adela, Inc.
- Adverum Biotechnologies, Inc.
- Alector, Inc.
- Alentis Therapeutics AG
- Apogee Therapeutics, Inc.
- Arcutis Biotherapeutics, Inc.
- ARS Pharmaceuticals, Inc.
- Arvinas, Inc.
- Ascendis Pharma A/S
- Athersys, Inc.
- Avalo Therapeutics, Inc.
- BioAge Labs, Inc.
- BioCryst Pharmaceuticals, Inc.
- Century Therapeutics, Inc.
- Convergent Therapeutics, Inc.
- Crinetics Pharmaceuticals, Inc.
- Edgewise Therapeutics, Inc.
- Electra Therapeutics, Inc.
- Enliven Therapeutics, Inc.
- Forward Therapeutics, Inc.
- Galecto, Inc.
- GentiBio, Inc.
- Invivyd, Inc.
- Jade Biosciences, Inc.
- Janux Therapeutics, Inc.
- KALA BIO, Inc.
- Keros Therapeutics, Inc.
- Larimar Therapeutics, Inc.
- MacroGenics, Inc.
- Magenta Medical LTD
- MBX Biosciences, Inc.
- Natera, Inc.
- Nautilus Biotechnology, Inc.
- Nucleix Ltd.
- Olema Pharmaceuticals, Inc.
- Pandion Operations, Inc.
- PMV Pharmaceuticals, Inc.
- ProfoundBio (Suzhou) Co., Ltd.
- Rampart Bioscience, Inc.
- Rhythm Pharmaceuticals, Inc.
- Scribe Therapeutics Inc.
- Sionna Therapeutics, Inc.
- Sparrow Pharmaceuticals, Inc.
- Star Therapeutics, Inc.
- Third Harmonic Bio, Inc.
- Tyra Biosciences, Inc.
- Verdiva Bio Limited
- X4 Pharmaceuticals, Inc.
- 37 shared
Shared portfolio companies
- Achilles Therapeutics plc
- Acrivon Therapeutics, Inc.
- Adagio Medical Holdings, Inc.
- Affinia Therapeutics, Inc.
- Alector, Inc.
- Apogee Therapeutics, Inc.
- Ardelyx, Inc.
- Arrowhead Pharmaceuticals, Inc.
- Arvinas, Inc.
- Astria Therapeutics, Inc.
- Avidity Biosciences, Inc.
- Benitec Biopharma Inc.
- Bicycle Therapeutics plc
- C4 Therapeutics, Inc.
- Cerebral Therapeutics, Inc.
- Collegium Pharmaceutical, Inc.
- Crinetics Pharmaceuticals, Inc.
- Day One Biopharmaceuticals, Inc.
- DBV Technologies S.A.
- Edgewise Therapeutics, Inc.
- Forge Biologics, Inc.
- Freenome Holdings, Inc.
- Galecto, Inc.
- GRAIL, Inc.
- LianBio
- Lite Strategy, Inc.
- Nautilus Biotechnology, Inc.
- NiKang Therapeutics, Inc.
- Pyxis Oncology, Inc.
- Rhythm Pharmaceuticals, Inc.
- Scribe Therapeutics Inc.
- Sionna Therapeutics, Inc.
- Solid Biosciences Inc.
- Synthego Corporation
- Taysha Gene Therapies, Inc.
- Tengion, Inc.
- TORL BioTherapeutics, LLC
- 26 shared
Shared portfolio companies
- Aclaris Therapeutics, Inc.
- Adverum Biotechnologies, Inc.
- Ajax Therapeutics, Inc.
- Arcutis Biotherapeutics, Inc.
- Ascendis Pharma A/S
- Aurinia Pharmaceuticals Inc.
- Avadel Pharmaceuticals plc
- Bolt Biotherapeutics, Inc.
- Cerebral Therapeutics, Inc.
- Coherus Oncology, Inc.
- DBV Technologies S.A.
- Immunic, Inc.
- IO Biotech ApS
- KALA BIO, Inc.
- Kira Pharmaceuticals
- Larimar Therapeutics, Inc.
- Legend Biotech Corporation
- Lite Strategy, Inc.
- MacroGenics, Inc.
- Medeor Therapeutics, Inc.
- Ocelot Bio, Inc.
- Olema Pharmaceuticals, Inc.
- Precision BioSciences, Inc.
- SAB Biotherapeutics, Inc.
- Tourmaline Bio, Inc.
- Unicycive Therapeutics, Inc.
- 21 shared
Shared portfolio companies
- Achilles Therapeutics plc
- Artios Pharma Limited
- Asher Biotherapeutics, Inc.
- Bambusa Therapeutics Inc.
- Bicara Therapeutics Inc.
- Boundless Bio, Inc.
- Bright Peak Therapeutics AG
- Convergent Therapeutics, Inc.
- Crinetics Pharmaceuticals, Inc.
- Edgewise Therapeutics, Inc.
- Hemab ApS
- Immunic, Inc.
- Iteos Therapeutics S.A.
- Lexeo Therapeutics, Inc.
- Locanabio, Inc.
- Moderna, Inc.
- NiKang Therapeutics, Inc.
- Parabilis Medicines, Inc.
- Rani Therapeutics Holdings, Inc.
- Solid Biosciences Inc.
- Taysha Gene Therapies, Inc.
- 20 shared
Shared portfolio companies
- Abcuro, Inc.
- Acrivon Therapeutics, Inc.
- Adaptimmune Therapeutics plc
- Affinia Therapeutics, Inc.
- Akari Therapeutics, Plc
- Ardelyx, Inc.
- Aurinia Pharmaceuticals Inc.
- Avalo Therapeutics, Inc.
- Galera Therapeutics, Inc.
- Geron Corporation
- Lite Strategy, Inc.
- Magenta Medical LTD
- MBX Biosciences, Inc.
- Nkarta, Inc.
- Phathom Pharmaceuticals, Inc.
- PHAXIAM Therapeutics S.A.
- Rhythm Pharmaceuticals, Inc.
- SpyGlass Pharma, Inc.
- Vitae Pharmaceuticals, Inc.
- X4 Pharmaceuticals, Inc.
- 20 shared
Shared portfolio companies
- Adaptimmune Therapeutics plc
- Adcendo ApS
- Alentis Therapeutics AG
- Bluejay Therapeutics, Inc.
- Claris Biotherapeutics, Inc.
- Convergent Therapeutics, Inc.
- Crinetics Pharmaceuticals, Inc.
- Edgewise Therapeutics, Inc.
- Galecto, Inc.
- Galera Therapeutics, Inc.
- Hemab ApS
- IO Biotech ApS
- KalVista Pharmaceuticals, Inc.
- Lexeo Therapeutics, Inc.
- Magenta Medical LTD
- Merus N.V.
- Metagenomi, Inc.
- Nkarta, Inc.
- Obsidian Therapeutics, Inc.
- Spero Therapeutics, Inc.
- 18 shared
Shared portfolio companies
- Abcuro, Inc.
- Atea Pharmaceuticals, Inc.
- C4 Therapeutics, Inc.
- Cidara Therapeutics, Inc.
- Dianthus Therapeutics, Inc.
- Freenome Holdings, Inc.
- Interius BioTherapeutics, Inc.
- Invivyd, Inc.
- Nautilus Biotechnology, Inc.
- NewAmsterdam Pharma Company N.V.
- Nimbus Therapeutics, LLC
- Olema Pharmaceuticals, Inc.
- Rivus Pharmaceuticals, Inc.
- Solid Biosciences Inc.
- Synthekine Inc.
- Tango Therapeutics, Inc.
- X4 Pharmaceuticals, Inc.
- Xilio Therapeutics, Inc.
- 18 shared
Shared portfolio companies
- Aclaris Therapeutics, Inc.
- Adverum Biotechnologies, Inc.
- Alpha-9 Theranostics, Inc.
- Arcutis Biotherapeutics, Inc.
- Avadel Pharmaceuticals plc
- Bellicum Pharmaceuticals, Inc.
- Cidara Therapeutics, Inc.
- Collegium Pharmaceutical, Inc.
- Crinetics Pharmaceuticals, Inc.
- Galera Therapeutics, Inc.
- Iterum Therapeutics plc
- MBX Biosciences, Inc.
- Metagenomi, Inc.
- NewAmsterdam Pharma Company N.V.
- Phathom Pharmaceuticals, Inc.
- Sojournix, Inc.
- Sutro Biopharma, Inc.
- Vaxcyte, Inc.
- 17 shared
Shared portfolio companies
- Affinia Therapeutics, Inc.
- Alector, Inc.
- Boundless Bio, Inc.
- Freenome Holdings, Inc.
- Invivyd, Inc.
- Locanabio, Inc.
- Nimbus Therapeutics, LLC
- Obsidian Therapeutics, Inc.
- Parabilis Medicines, Inc.
- Rani Therapeutics Holdings, Inc.
- Spero Therapeutics, Inc.
- SynaptiCure, Inc.
- Taysha Gene Therapies, Inc.
- Tenaya Therapeutics, Inc.
- Trace Neuroscience, Inc.
- TScan Therapeutics, Inc.
- Ventus Therapeutics U.S., Inc.
- 14 shared
Shared portfolio companies
.png)
